The Oklahoma Supreme Court overturned a $465M opioid ruling against Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law.

Tagged with: johnson & johnson opioids

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

Tagged with: opioids pharmaceutical companies

A federal judge allowed Purdue Pharma to resume its work carrying out the recent $10 billion settlement plan that allowed the Oxycontin maker to emerge from bankruptcy.

Tagged with: opioids purdue pharma

There is no evidence that retail pharmacy chains contributed to the opioid crisis, attorneys for three of the companies argued during opening statements.

Tagged with: drugs opioids pharmacy

In a bellwether federal trial, two Ohio counties will try to convince a jury that retail pharmacy companies played an outsized role in the ongoing opioid crisis.

Tagged with: opioids pharmacy

Objections to a historic settlement with Purdue Pharma are mounting, with one attorney general saying the plan doesn't hold the OxyContin maker or its owners accountable.

Tagged with: opioids purdue pharma

A judge formally approved a plan to turn OxyContin maker Purdue Pharma into a new company with its profits going to fight the opioid epidemic.

Tagged with: drugs opioids oxycontin

Four drug companies said enough states had agreed to a settlement of lawsuits over the opioid crisis for them to move ahead with the $26 billion deal.

Tagged with: opioids

The prospect of families who lost loved ones in the opioid crisis facing OxyContin maker Purdue Pharma and its owners in a courtroom all but vanished Wednesday.

Tagged with: drugs opioids oxycontin

A federal judge gave conditional approval to a sweeping plan to settle a mountain of lawsuits over OxyContin maker Purdue Pharma's role in the opioid crisis.

Tagged with: Bankruptcy opioids oxycontin